In Early 2021 Israel and Pfizer Knew COVID Shots Caused Fatal Heart Condition — But Waited Months Before Alerting Public, according to Peer Reviewed Study Using Gov Data

From [HERE] Pfizer and Israel’s Ministry of Health (MOH) knew in early 2021 about a significant “cardiac event” safety signal associated with Pfizer’s COVID-19 vaccine — but withheld the information from physicians and the public for several months, a new peer-reviewed study has found.

The authors of the study, published last week in EXCLI Journal, reviewed an MOH dataset containing 531 hospitalization records dating from March 2021 — just months after the rollout of the mRNA Pfizer-BioNTech shot — to May 2022.

The records included 67 deaths, including nine in patients under age 50. Two of the nine deaths were attributed to myocarditis, which can lead to cardiac arrhythmia and death.

Myocarditis was recorded in 71.6% of the hospitalization records involving patients under 30. Nearly two-thirds of those patients “had no meaningful medical history” before their diagnosis.

The deaths and injuries were reported to Israel’s MOH and to Pfizer. Yet, public health authorities in Israel, the U.S. and elsewhere downplayed the safety signal, reporting it “only after a delay of approximately three to four months.”

Even then, health authorities described most cases as “rare” or “mild” — and of less concern than the risk COVID-19 posed.

Karl Jablonowski, Ph.D., senior research scientist for Children’s Health Defense (CHD), said none of the myocarditis deaths are found in the U.S. government’s Vaccine Adverse Event Reporting System (VAERS), even though Pfizer was obligated to report the deaths to VAERS.

“The bereaved and the injured are owed an answer,” Jablonowski said.

Steve Kirsch, founder of the Vaccine Safety Research Foundation, said the study’s findings are significant because they are based on “internal government data” instead of data from vaccine makers or from publicly available databases.

Kirsch said the data show that Israel’s MOH “was clearly more interested in protecting the manufacturers than the public.” [MORE]